Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
nanoBioSciences is a private U.S. medical device and drug-delivery company focused on microneedle-based transdermal and intradermal delivery technologies. The company, which also operates under the name AdminMed, has developed the AdminPatch microneedle array platform and the AdminPen hollow microneedle injection device for painless delivery of drugs, vaccines, biologics, and cosmetic actives through the skin. Its strategy appears to emphasize enabling delivery of already approved drugs and formulations rather than developing novel therapeutics, which positions it more as a platform and device company than a traditional clinical-stage biotech. The company markets evaluation products and services directly from its website and highlights applications across vaccines, immunotherapies, dermatology, rheumatology, diabetes-related injection use cases, and biosensing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on nanoBioSciences.